CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union
13 juin 2024 07h00 HE
|
CytoSorbents
The launch of the PuriFi hemoperfusion machine is expected to increase the demand and sales of CytoSorbents’ leading CytoSorb® blood purification therapy
Dedicated HCPCS Billing Code for Arch Therapeutics’ AC5® Advanced Wound System Now In Effect
05 avr. 2023 06h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., April 05, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
InnerScope Hearing Technologies (OTC: INND) Announces New Internal Hearing Aid Sales & Hearing Care Professional Call Center
23 févr. 2022 08h00 HE
|
InnerScope Hearing Technologies, Inc.
Staffed by a Highly Experienced Team of Licensed Hearing Professionals and Leading Salespeople from Competitor PlatformsAims to Enhance Customer Experience and Deliver Revenue Growth ROSEVILLE,...
Interpace Diagnostics Announces New Coverage of Thyroid Testing by Medica
02 avr. 2019 06h55 HE
|
Interpace Diagnostics Group, Inc.
Key Regional Health Plan Further Expands Number of Covered Lives to Over 280 Million PARSIPPANY, NJ, April 02, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced...
XYMOGEN Launches Pharmaceutix(TM) Medical Foods Division and Partners With Acasti Pharma to Bring Revolutionary Medical Food to United States and Beyond
11 juil. 2012 08h37 HE
|
XYMOGEN
ORLANDO, Fla., July 11, 2012 (GLOBE NEWSWIRE) -- XYMOGEN announced today an exclusive partnership with Acasti Pharma, the biopharmaceutical company with whom they will launch the worldwide...
H. Lundbeck and Pharmexa Achieve Important Milestone in Research Collaboration
10 déc. 2002 10h48 HE
|
Pharmexa A/S
HORSHOLM, Denmark, Dec. 10, 2002 (PRIMEZONE) -- Pharmexa (Other OTC:PMXAY) today announced important progress in a research collaboration with H. Lundbeck established in April 2000. The focus of the...
Ortivus: Interim Report, January - September 2002
28 oct. 2002 08h05 HE
|
Ortivus
STOCKHOLM, Sweden, Oct. 28, 2002 (PRIMEZONE) -- Ortivus AB (publ) (Other OTC:ORIVF) (Stockholm:ORTIa):
Significant events during the period:
- Sales were up 19 percent to MSEK 125.9 (105.8...
Cardio Control Q3: Sales Doubled, Record Earnings Expected for 2002
15 oct. 2002 09h45 HE
|
Cardio Control NV
DELFT, The Netherlands, Oct. 15, 2002 (PRIMEZONE) -- Cardio Control NV has doubled its sales in the 3rd quarter compared with the same quarter last year. Sales amounted to EUR 2,4 mln compared to EUR...
Getinge: Interim Report, June 2002
15 juil. 2002 02h39 HE
|
Getinge
STOCKHOLM, Sweden, July 15, 2002 (PRIMEZONE) -- Getinge:
-- Heraeus acquisition concluded during Q2 - significant synergy effects
-- The Q2 profit before tax rose by 22%
-- The profit before tax...
CardioDynamics: Study on BioZ ICG Validates Noninvasive Technology as Equivalent to Pulmonary Artery Catheter
12 mars 2002 07h00 HE
|
CardioDynamics International Corporation
SAN DIEGO, March 12, 2002 (PRIMEZONE) -- CardioDynamics (Nasdaq:CDIC), the innovator and global leader of Impedance Cardiography (ICG) technology, today announced that a significant ICG study was...